Bain Capital GSS Investment
BCSS
10.22
0.00
0.00%
Bain Capital GSS Investment
US · BCSS
#3630 by market cap
Listed 2025
10.22
0.00
0.00%
Live - 5344 symbols - heartbeat 153s ago
· 2026-10-07 19:54
After-hours
10.22
0.00%
- Market cap
- 596.85M
- P/E (TTM)i
- 0.00
- P/Bi
- 1.30
- EPSi
- 0.00
- Div yieldi
- 0.00%
- 52W posi
- 51%
Reader sentiment
Are you bullish or bearish on BCSS?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 1 years
Balance sheet
| Line item | 2025 |
|---|---|
| Total current assets | 1.02M |
| Cash & ST investments | 784.95K |
| Inventory | -- |
| Total assets | 465.84M |
| Total current liabilities | 291.71K |
| Short-term debt | -- |
| Long-term debt | -- |
| Total liabilities | 16,391,711.00 |
| Total equity | 449.45M |
| Retained earnings | -15.20M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 25.00K | 25.00K | 2.00M | -- | 932.23K | 892.19K |
| Cash & ST investments | -- | -- | 2.00M | -- | 637.19K | 622.02K |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 80.33K | 240.26K | 9.61M | -- | 469.96M | 474.17M |
| Total current liabilities | 75.93K | 265.83K | 9.65M | -- | 401.80K | 655.87K |
| Short-term debt | -- | 10.42K | 212.38K | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 75,933.00 | 265,825.00 | 9,654,068.00 | -- | 16,501,797.00 | 16,755,874.00 |
| Total equity | 4.39K | -25.57K | -46.17K | -- | 453.46M | 457.41M |
| Retained earnings | -20.61K | -50.57K | -71.17K | -- | -15.46M | -15.81M |
Returns & efficiency
| Line item | 2025 |
|---|---|
| ROE %i | -- |
| ROA %i | -- |
| ROIC %i | -- |
| 5-year avg ROE %i | -- |
| EBIT margin %i | -- |
| FCF / sales %i | -- |
| Current ratioi | 3.51 |
| Quick ratioi | 2.69 |
| Debt / assetsi | -- |
| LT debt / equityi | -- |
| Interest coveragei | -- |
| Revenue CAGR (3Y) %i | -- |
| Net income CAGR (3Y) %i | -- |
| FCF CAGR (3Y) %i | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | -- | -- | -- | -- | -- | -- |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.33 | 0.09 | 0.21 | -- | 2.32 | 1.36 |
| Quick ratioi | -- | -- | 0.21 | -- | 1.59 | 0.95 |
| Debt / assetsi | -- | 4.34 | 2.21 | -- | -- | -- |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.